Navigation Links
ALine, Inc. Expands Management, Adding Roger Anderson, Ph.D., as VP of Operations
Date:11/6/2008

ALine increases microfabrication business development capabilities by hiring laboratory reagent and diagnostics industry veteran

(PRWEB) November 6, 2008 -- ALine, Inc., a high-tech provider of rapid prototyping and manufacturing services for microfluidic devices, welcomes Roger Anderson, PhD, as the Vice President of Operations. Dr. Anderson brings years of entrepreneurial and business growth experience to the Company.

Leanna M. Levine, President and CEO of ALine, Inc. in making the announcement said, "We are pleased to have Dr. Anderson on our management team. His background in business development and molecular biology will allow us to pursue new product opportunities and expand into new markets. His success in new product development, product management, and experience in entrepreneurial ventures, will accelerate the growth of our business as we expand our offering of biomicrofluidic solutions. We anticipate new opportunities to provide lab on a chip solutions for point of care, laboratory, and fieldable instrumentation through Joint Ventures and OEM partnerships."
   
On accepting the position, Dr. Anderson commented, "I am excited about participating in the growth of ALine as it serves the Home testing, field portable and point of care diagnostics markets. ALine is uniquely positioned to address the prototyping and manufacturing needs of this burgeoning sector."

Dr. Anderson has started or participated in the start of six companies. Prior to joining ALine, Dr. Anderson held various executive positions including Division Manager for Immunobiologicals at MP Biomedicals (formerly ICN Biomedicals), President of BioCarta in San Diego (a proteomics reagent manufacturer and distributor), as well as CTO and founder of Anderson Unicom Group (An informatics company that created the industry's largest and most complete multi-supplier catalog to support online purchasing of laboratory reagents and supplies.

ALine's enabling microfabrication platform permits rapid prototyping, custom development, and volume fabrication of sophisticated self-contained fluidic devices suitable for unique or multiplex single use applications. The ability to incorporate numerous channels and functions, such as pneumatically actuated valves, in polymer laminate devices permits device developers to incorporate complex functionality for multiplexed analysis.

ALine's fabrication process enables and supports developers from prototyping to manufacture. The Company currently manufactures over 10,000 complex laminate fluidic components per month in compliance with FDA quality guidelines. Current and former customers include Abbott Laboratories, Baxter Healthcare, Invitrogen, Bio-Rad, NASA, and the City of Hope, as well as academic institutions like Stanford, Cornell, and the University of Washington.

For more information Contact:
ALine, Inc
PO Box 1068
Redondo Beach, CA 90278
www.alineinc.com
877-707-8575

# # #

Read the full story at http://www.prweb.com/releases/2008/11/prweb1573664.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related biology technology :

1. ATS Medical Expands Open Pivot Heart Valve Offerings
2. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
3. BioLife Solutions Expands Scientific Advisory Board
4. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
5. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
6. Pharsight Expands Strategic Consulting Services Team
7. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
8. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
9. AQUISS Expands Into Significant New Territory
10. NanoBio Expands Drug Development Team for Its Anti-Infective Products
11. BitWine (TM) Nutrition Advisors Network Expands Roster of Licensed Dietitians and Nutritionists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 2017  Market Research Future has a half cooked research report ... is growing rapidly and expected to reach USD 450 Million by ... ... Market has been assessed as a swiftly growing market and expected ... the coming future. There has been a tremendous growth in the ...
(Date:1/19/2017)... -- WuXi AppTec, a leading global pharmaceutical, biotechnology ... today announced that it has acquired HD Biosciences ... contract research organization (CRO). After completion of acquisition, ... WuXi, and will continue to focus on growing ... acquisition will further strengthen WuXi,s R&D capability from ...
(Date:1/19/2017)... ... January 19, 2017 , ... Genedata, ... (R&D), today announced the launch of Data Science Services , offering ... evolving field of precision medicine. , Data Science Services allows pharmaceutical ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, ... Altimmune, Inc., a privately-held immunotherapeutics company targeting infectious ... agreement for the merger of PharmAthene and Altimmune ... Novartis Venture Fund, HealthCap, Truffle Capital and Redmont ... and diversified immunotherapeutics company with four clinical stage ...
Breaking Biology Technology:
(Date:1/6/2017)...  Delta ID Inc., a leader in consumer-grade iris ... at CES® 2017. Delta ID has collaborated with Gentex ... use of iris scanning as a secure, reliable and ... a car, and as a way to elevate the ... Delta ID and Gentex will demonstrate (booth #7326 LVCC) ...
(Date:12/22/2016)... MOUNTAIN VIEW, Calif. , Dec. 20, 2016  As ... all levels, 23andMe, the leading personal genetics company, recently released ... Only Me . The book focuses on the topics ... the Next Generation Science Standards (NGSS) taught in elementary school ... the second in a series by illustrator Ariana Killoran ...
(Date:12/19/2016)... 19 de diciembre de 2016  Mosaic Biomedicals SL anunció hoy ... de MSC-1, un anticuerpo humanizado que se espera comenzar a utilizar ... múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el primer ... leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos tumores ...
Breaking Biology News(10 mins):